Advertisement
Advertisement
LABVOLUTION 2019, 21 - 23 May
Logo SynAbs

SynAbs

Logo SynAbs

Hall 20, Stand E13

(Main stand)

Company

2015
Year founded
1-10
No. of employees
(Status: 2017)
less than 1 million EUR
Annual turnover
(Status: 2017)

In order to overtake mouse species limitations, SynAbs is offering stable hybridoma of rat and guinea pig to generate:

- an extensive catalog of ready-to-use monoclonal antibodies like anti-DNP, anti-isotypes, isotype controls, anti-species,...

https://www.synabs.be/our-antibody-products/

- your custom monoclonal antibodies against difficult and poor immunogenic antigens (interleukin, glucagon, HIV, antibiotics, toxins, peptides, steroids, small molecules...) thanks to our singular antigenic repertoire access, with a multi species approach (mouse, rat and guinea pig).

https://www.synabs.be/rat-monoclonal-antibodies/

- an integrated service offer from the antigen synthesis, its coupling, parallel immunization, the generation of stable clones, the production manner of several grams of mAbs and immunoaffinity assays development.

https://www.synabs.be/custom-generation-of-high-affinity-mabs/

  • Company Data
  • Contacts
Company Data

SynAbs SA

I-Tech Incubator 2, Aile Piccard, +1
Rue Auguste Piccard, 48
6041 Gosselies Belgium

Contacts

Stored items

0

Server communication error: Item could not be saved.